Addressing reimbursement disparities for direct-acting antiviral therapies for hepatitis C virus infection is essential to ensure access for all.
The Kirby Institute, UNSW Australia, Sydney, NSW, Australia.
J
J
Grebely
Division of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.
A
A
Litwin
The Kirby Institute, UNSW Australia, Sydney, NSW, Australia.
G J
GJ
Dore
D000998:Antiviral Agents; D016174:Hepacivirus; D006526:Hepatitis C; D006801:Humans; D015819:Substance Abuse, Intravenous
D000998:Antiviral Agents
IFN-free; PWID; drug users; hepatitis C virus; injecting; injection